Sunshine Biopharma
SBFM
5 hedge funds and large institutions have $262K invested in Sunshine Biopharma in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
15% less capital invested
Capital invested by funds: $308K → $262K (-$46.5K)
29% less funds holding
Funds holding: 7 → 5 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$31.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$29K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$13K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
1
Bridgeway Capital Management
Houston,
Texas
| $183K | – | – | – |
|
|
VF
2
Virtu Financial
New York
| $23K | +$31.9K | +2 | New |
|
3
Bank of Montreal
Toronto,
Ontario, Canada
| $21.6K | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $12K | – | – | – |
|
5
Bank of America
Charlotte,
North Carolina
| $8.88K | – | – | – |
|
6
UBS Group
Zurich,
Switzerland
| $4.62K | – | – | – |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $4K | – | – | – |
|
8
National Bank of Canada
Montreal,
Quebec, Canada
| $3.87K | – | – | – |
|
|
NECFA
9
New England Capital Financial Advisors
Meriden,
Connecticut
| $490 | – | – | – |
|
|
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $51 | – | – | – |
|
|
11
Two Sigma Investments
New York
| – | -$29K | -2 | Closed |
|
|
12
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$11K | -1 | Closed |
|
|
TSS
13
Two Sigma Securities
New York
| – | -$13K | -1 | Closed |
|
SBFM Hedge Fund Activity: Q4 2022 in Review
5 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q4 2022, worth a combined $262K — down 15% from $308K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SBFM and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $31.9K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $29K sold.
- 5 institutional investors held Sunshine Biopharma (SBFM) as of Q4 2022, down from 7 in Q3 2022.
- Funds reported $262K of Sunshine Biopharma stock for Q4 2022, down 15% quarter-over-quarter.
- 1 fund opened new Sunshine Biopharma positions in Q4 2022 and 3 closed out, a net change of -2 holders.
- The largest Sunshine Biopharma buyer in Q4 2022 was Virtu Financial, an estimated $31.9K added.
- The largest Sunshine Biopharma seller in Q4 2022 was Two Sigma Investments, an estimated $29K sold.
Based on aggregated 13F filings for Q4 2022.